{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:18:21Z","timestamp":1792610301772,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.bbrc.2021.03.162","type":"journal-article","created":{"date-parts":[[2021,4,9]],"date-time":"2021-04-09T17:07:51Z","timestamp":1617988071000},"page":"185-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival"],"prefix":"10.1016","volume":"556","author":[{"given":"Marie","family":"Ishiura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Kitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kashiwakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7474-493X","authenticated-orcid":false,"given":"Ryuta","family":"Muromoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0297-5640","authenticated-orcid":false,"given":"Jun","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0018-6656","authenticated-orcid":false,"given":"Michiko","family":"Ichii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Oritani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3089-3757","authenticated-orcid":false,"given":"Tadashi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.03.162_bib1","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2008-03-144790","article-title":"Molecular biology of bcr-abl1-positive chronic myeloid leukemia","volume":"113","author":"Quintas-Cardama","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.03.162_bib2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.bbrc.2021.03.162_bib3","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","article-title":"Chroniques Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial","volume":"11","author":"Mahon","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2021.03.162_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1182\/blood-2013-02-483750","article-title":"Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study","volume":"122","author":"Ross","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.03.162_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(18)30192-X","article-title":"EURO-SKI investigators, Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial","volume":"19","author":"Saussele","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrc.2021.03.162_bib6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/bbrc.2000.2223","article-title":"Molecular cloning of murine STAP-1, the stem-cell-specific adaptor protein containing PH and SH2 domains","volume":"268","author":"Masuhara","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.03.162_bib7","doi-asserted-by":"crossref","first-page":"11182","DOI":"10.1074\/jbc.M211230200","article-title":"STAP-2\/BKS, an adaptor\/docking protein, modulates STAT3 activation in acute-phase response through its YXXQ motif","volume":"278","author":"Minoguchi","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.03.162_bib8","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1074\/jbc.M411692200","article-title":"Physical and functional interactions between STAP-2\/BKS and STAT5","volume":"280","author":"Sekine","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.03.162_bib9","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1349-7006.2010.01842.x","article-title":"Involvement of STAP-2 in Brk-mediated phosphorylation and activation of STAT5 in breast cancer cells","volume":"102","author":"Ikeda","year":"2011","journal-title":"Canc. Sci."},{"key":"10.1016\/j.bbrc.2021.03.162_bib10","doi-asserted-by":"crossref","first-page":"4384","DOI":"10.1038\/onc.2011.604","article-title":"STAP-2 interacts with and modulates BCR-ABL-mediated tumorigenesis","volume":"31","author":"Sekine","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.03.162_bib11","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bbrc.2015.06.020","article-title":"CCR7 is involved in BCR-ABL\/STAP-2-mediated cell growth in hematopoietic Ba\/F3 cells","volume":"463","author":"Kubo","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.03.162_bib12","doi-asserted-by":"crossref","first-page":"5601","DOI":"10.1038\/s41388-020-01387-9","article-title":"Signal-transducing adapter protein-1 is required for maintenance of leukemic stem cells in CML","volume":"39","author":"Toda","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.03.162_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241440","article-title":"Expression of signal-transducing adaptor protein-1 attenuates experimental autoimmune hepatitis via down-regulating activation and homeostasis of invariant natural killer T cells","volume":"15","author":"Kashiwakura","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.bbrc.2021.03.162_bib14","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4049\/jimmunol.177.2.1160","article-title":"Sumoylation of Daxx regulates IFN-induced growth suppression of B-lymphocytes and the hormone receptor-mediated transactivation","volume":"177","author":"Muromoto","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2021.03.162_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/immunohorizons.1900023","article-title":"I\u03baB-\u03b6 expression requires both TYK2\/STAT3 activity and IL-17-regulated mRNA stabilization","volume":"3","author":"Muromoto","year":"2019","journal-title":"ImmunoHorizons"},{"key":"10.1016\/j.bbrc.2021.03.162_bib16","doi-asserted-by":"crossref","first-page":"19392","DOI":"10.1074\/jbc.M117.802884","article-title":"STAP-2 protein promotes prostate cancer growth by enhancing epidermal growth factor receptor stabilization","volume":"292","author":"Kitai","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2021.03.162_bib17","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1074-7613(00)80188-0","article-title":"Manipulating immune responses with immunosuppressive agents that target NFAT","volume":"12","author":"Kiani","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.bbrc.2021.03.162_bib18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nri2818","article-title":"NFAT, immunity and cancer: a transcription factor comes of age","volume":"10","author":"M\u00fcller","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2021.03.162_bib19","doi-asserted-by":"crossref","first-page":"11976","DOI":"10.1073\/pnas.96.21.11976","article-title":"Molecular cloning of a docking protein, BRDG1, that acts downstream of the Tec tyrosine kinase","volume":"96","author":"Ohya","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bbrc.2021.03.162_bib20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbrc.2008.12.021","article-title":"Induction of STAP-1 promotes neurotoxic activation of microglia","volume":"379","author":"Stoecker","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.03.162_bib21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.115.304660","article-title":"Mutations in STAP1 are associated with autosomal dominant hypercholesterolemia","volume":"115","author":"Fouchier","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2021.03.162_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.cca.2018.10.014","article-title":"A\u00a0rare STAP1 mutation incompletely associated with familial hypercholesterolemia","volume":"487","author":"Blanco-Vaca","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.bbrc.2021.03.162_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.atherosclerosis.2019.11.025","article-title":"Predicted pathogenic mutations in STAP1 are not associated with clinically defined familial hypercholesterolemia","volume":"292","author":"Lamiquiz-Moneo","year":"2020","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2021.03.162_bib24","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/ATVBAHA.119.313470","article-title":"Taking one step back in familial hypercholesterolemia: STAP1 does not alter plasma LDL (Low-Density Lipoprotein) cholesterol in mice and humans","volume":"40","author":"Loaiza","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bbrc.2021.03.162_bib25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41598-017-17704-4","article-title":"Therapeutic target in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"8","author":"Steeghs","year":"2018","journal-title":"Sci. Rep."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21005751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21005751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:05:11Z","timestamp":1757765111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21005751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":25,"alternative-id":["S0006291X21005751"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.162","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positive interactions between STAP-1 and BCR-ABL influence chronic myeloid leukemia cell proliferation and survival","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.162","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}